ALS 患者大脑微结构退化的时间和空间进展:多中心纵向弥散张量成像研究

IF 3.4 2区 医学 Q2 NEUROIMAGING
Hans-Peter Müller , Agessandro Abrahao , Christian Beaulieu , Michael Benatar , Annie Dionne , Angela Genge , Richard Frayne , Simon J. Graham , Summer Gibson , Lawrence Korngut , Collin Luk , Robert C. Welsh , Lorne Zinman , Jan Kassubek , Sanjay Kalra
{"title":"ALS 患者大脑微结构退化的时间和空间进展:多中心纵向弥散张量成像研究","authors":"Hans-Peter Müller ,&nbsp;Agessandro Abrahao ,&nbsp;Christian Beaulieu ,&nbsp;Michael Benatar ,&nbsp;Annie Dionne ,&nbsp;Angela Genge ,&nbsp;Richard Frayne ,&nbsp;Simon J. Graham ,&nbsp;Summer Gibson ,&nbsp;Lawrence Korngut ,&nbsp;Collin Luk ,&nbsp;Robert C. Welsh ,&nbsp;Lorne Zinman ,&nbsp;Jan Kassubek ,&nbsp;Sanjay Kalra","doi":"10.1016/j.nicl.2024.103633","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>The corticospinal tract (CST) reveals progressive microstructural alterations in ALS measurable by DTI. The aim of this study was to evaluate fractional anisotropy (FA) along the CST as a longitudinal marker of disease progression in ALS.</p></div><div><h3>Methods</h3><p>The study cohort consisted of 114 patients with ALS and 110 healthy controls from the second prospective, longitudinal, multicentre study of the Canadian ALS Neuroimaging Consortium (CALSNIC-2). DTI and clinical data from a harmonized protocol across 7 centres were collected. Thirty-nine ALS patients and 61 controls completed baseline and two follow-up visits and were included for longitudinal analyses. Whole brain-based spatial statistics and hypothesis-guided tract-of-interest analyses were performed for cross-sectional and longitudinal analyses.</p></div><div><h3>Results</h3><p>FA was reduced at baseline and longitudinally in the CST, mid-corpus callosum (CC), frontal lobe, and other ALS-related tracts, with alterations most evident in the CST and mid-CC. CST and pontine FA correlated with functional impairment (ALSFRS-R), upper motor neuron function, and clinical disease progression rate. Reduction in FA was largely located in the upper CST; however, the longitudinal decline was greatest in the lower CST. Effect sizes were dependent on region, resulting in study group sizes between 17 and 31 per group over a 9-month interval. Cross-sectional effect sizes were maximal in the upper CST; whereas, longitudinal effect sizes were maximal in mid-callosal tracts.</p></div><div><h3>Conclusions</h3><p>Progressive microstructural alterations in ALS are most prominent in the CST and CC. DTI can provide a biomarker of cerebral degeneration in ALS, with longitudinal changes in white matter demonstrable over a reasonable observation period, with a feasible number of participants, and within a multicentre framework.</p></div>","PeriodicalId":54359,"journal":{"name":"Neuroimage-Clinical","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S221315822400072X/pdfft?md5=5fef73c3f46e2dde46f979f9533ebae9&pid=1-s2.0-S221315822400072X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging study\",\"authors\":\"Hans-Peter Müller ,&nbsp;Agessandro Abrahao ,&nbsp;Christian Beaulieu ,&nbsp;Michael Benatar ,&nbsp;Annie Dionne ,&nbsp;Angela Genge ,&nbsp;Richard Frayne ,&nbsp;Simon J. Graham ,&nbsp;Summer Gibson ,&nbsp;Lawrence Korngut ,&nbsp;Collin Luk ,&nbsp;Robert C. Welsh ,&nbsp;Lorne Zinman ,&nbsp;Jan Kassubek ,&nbsp;Sanjay Kalra\",\"doi\":\"10.1016/j.nicl.2024.103633\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>The corticospinal tract (CST) reveals progressive microstructural alterations in ALS measurable by DTI. The aim of this study was to evaluate fractional anisotropy (FA) along the CST as a longitudinal marker of disease progression in ALS.</p></div><div><h3>Methods</h3><p>The study cohort consisted of 114 patients with ALS and 110 healthy controls from the second prospective, longitudinal, multicentre study of the Canadian ALS Neuroimaging Consortium (CALSNIC-2). DTI and clinical data from a harmonized protocol across 7 centres were collected. Thirty-nine ALS patients and 61 controls completed baseline and two follow-up visits and were included for longitudinal analyses. Whole brain-based spatial statistics and hypothesis-guided tract-of-interest analyses were performed for cross-sectional and longitudinal analyses.</p></div><div><h3>Results</h3><p>FA was reduced at baseline and longitudinally in the CST, mid-corpus callosum (CC), frontal lobe, and other ALS-related tracts, with alterations most evident in the CST and mid-CC. CST and pontine FA correlated with functional impairment (ALSFRS-R), upper motor neuron function, and clinical disease progression rate. Reduction in FA was largely located in the upper CST; however, the longitudinal decline was greatest in the lower CST. Effect sizes were dependent on region, resulting in study group sizes between 17 and 31 per group over a 9-month interval. Cross-sectional effect sizes were maximal in the upper CST; whereas, longitudinal effect sizes were maximal in mid-callosal tracts.</p></div><div><h3>Conclusions</h3><p>Progressive microstructural alterations in ALS are most prominent in the CST and CC. DTI can provide a biomarker of cerebral degeneration in ALS, with longitudinal changes in white matter demonstrable over a reasonable observation period, with a feasible number of participants, and within a multicentre framework.</p></div>\",\"PeriodicalId\":54359,\"journal\":{\"name\":\"Neuroimage-Clinical\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S221315822400072X/pdfft?md5=5fef73c3f46e2dde46f979f9533ebae9&pid=1-s2.0-S221315822400072X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroimage-Clinical\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S221315822400072X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"NEUROIMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroimage-Clinical","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221315822400072X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROIMAGING","Score":null,"Total":0}
引用次数: 0

摘要

目的通过 DTI 测量,皮质脊髓束(CST)显示出渐进性 ALS 的微结构改变。研究队列由加拿大 ALS 神经影像联盟 (CALSNIC-2) 第二项前瞻性纵向多中心研究中的 114 名 ALS 患者和 110 名健康对照者组成。研究人员在 7 个中心收集了统一方案下的 DTI 和临床数据。39 名 ALS 患者和 61 名对照者完成了基线和两次随访,并被纳入纵向分析。结果在基线和纵向上,CST、胼胝体中部(CC)、额叶和其他ALS相关束的FA均降低,其中CST和胼胝体中部的改变最为明显。CST和桥脑FA与功能障碍(ALSFRS-R)、上运动神经元功能和临床疾病进展率相关。FA的降低主要发生在CST上部;然而,纵向下降幅度最大的是CST下部。效应大小取决于不同的区域,因此在9个月的间隔期内,每组的研究人数在17至31人之间。横向效应大小在 CST 上部最大;而纵向效应大小在中胼胝体束最大。DTI 可以为 ALS 的大脑变性提供生物标志物,在合理的观察期内,在可行的参与人数和多中心框架内,白质的纵向变化是可以证明的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging study

Objective

The corticospinal tract (CST) reveals progressive microstructural alterations in ALS measurable by DTI. The aim of this study was to evaluate fractional anisotropy (FA) along the CST as a longitudinal marker of disease progression in ALS.

Methods

The study cohort consisted of 114 patients with ALS and 110 healthy controls from the second prospective, longitudinal, multicentre study of the Canadian ALS Neuroimaging Consortium (CALSNIC-2). DTI and clinical data from a harmonized protocol across 7 centres were collected. Thirty-nine ALS patients and 61 controls completed baseline and two follow-up visits and were included for longitudinal analyses. Whole brain-based spatial statistics and hypothesis-guided tract-of-interest analyses were performed for cross-sectional and longitudinal analyses.

Results

FA was reduced at baseline and longitudinally in the CST, mid-corpus callosum (CC), frontal lobe, and other ALS-related tracts, with alterations most evident in the CST and mid-CC. CST and pontine FA correlated with functional impairment (ALSFRS-R), upper motor neuron function, and clinical disease progression rate. Reduction in FA was largely located in the upper CST; however, the longitudinal decline was greatest in the lower CST. Effect sizes were dependent on region, resulting in study group sizes between 17 and 31 per group over a 9-month interval. Cross-sectional effect sizes were maximal in the upper CST; whereas, longitudinal effect sizes were maximal in mid-callosal tracts.

Conclusions

Progressive microstructural alterations in ALS are most prominent in the CST and CC. DTI can provide a biomarker of cerebral degeneration in ALS, with longitudinal changes in white matter demonstrable over a reasonable observation period, with a feasible number of participants, and within a multicentre framework.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Neuroimage-Clinical
Neuroimage-Clinical NEUROIMAGING-
CiteScore
7.50
自引率
4.80%
发文量
368
审稿时长
52 days
期刊介绍: NeuroImage: Clinical, a journal of diseases, disorders and syndromes involving the Nervous System, provides a vehicle for communicating important advances in the study of abnormal structure-function relationships of the human nervous system based on imaging. The focus of NeuroImage: Clinical is on defining changes to the brain associated with primary neurologic and psychiatric diseases and disorders of the nervous system as well as behavioral syndromes and developmental conditions. The main criterion for judging papers is the extent of scientific advancement in the understanding of the pathophysiologic mechanisms of diseases and disorders, in identification of functional models that link clinical signs and symptoms with brain function and in the creation of image based tools applicable to a broad range of clinical needs including diagnosis, monitoring and tracking of illness, predicting therapeutic response and development of new treatments. Papers dealing with structure and function in animal models will also be considered if they reveal mechanisms that can be readily translated to human conditions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信